Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2023-05-31 Interim / Quarterly Rep…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Management Board Report Selvita Q1 2023 ENG
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Consolidated Q1 2023 Report' for Selvita Capital Group. It contains detailed financial statements, including balance sheets, profit and loss statements, and cash flow data for the period ending March 31, 2023. It provides comprehensive management commentary and analysis of financial results, fitting the definition of an Interim/Quarterly Report. Q1 2023
2023-05-31 English
Consolidated Financial Statement Selvita Q1 2023 ENG
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Condensed Consolidated Financial Statements' for the period 01/01/2023 to 31/03/2023. It contains comprehensive financial statements, including the statement of comprehensive income, statement of financial position, and detailed explanatory notes. It is a full quarterly report, not an announcement or a summary, and thus fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-31 English
Jednostkowe Sprawozdanie Finansowe Selvita Q1 2023 PL
Interim / Quarterly Report Classification · 100% confidence The document is a formal financial report ('Sprawozdanie finansowe') for Selvita S.A. covering the period from 01.01.2023 to 31.03.2023. It includes detailed sections such as the balance sheet, income statement, cash flow statement, and accounting policies. Since it covers a period shorter than a full fiscal year (a quarter) and contains substantive financial data, it is classified as an Interim/Quarterly Report. Q1 2023
2023-05-31 Polish
Draft resolutions for GSM of Selvita 2023
AGM Information Classification · 100% confidence The document explicitly states it contains 'Resolution No. X of the Annual General Shareholders Meeting of Selvita S.A.' dated June 27, 2023. It details the resolutions passed regarding the election of the chairman, approval of the agenda, approval of management reports and financial statements for FY 2022, profit distribution, and crucially, the granting of discharge to members of the Management Board and Supervisory Board. These are core components of the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the classification should be AGM-R (AGM Information).
2023-05-31 English
Projekt uchwał na Walne Zgromadzenie Akcjonariuszy Selvita 2023
AGM Information Classification · 99% confidence The document text consists of multiple numbered resolutions ("Uchwała nr X") passed by the "Zwyczajne Walne Zgromadzenie" (Ordinary General Meeting) of Selvita S.A. on June 27, 2023. Key topics covered include electing the chairman, approving the agenda, approving financial statements and management reports for the 2022 fiscal year, approving the profit distribution, and granting discharge (absolutorium) to members of the Management Board and Supervisory Board for their duties in 2022. The core subject matter—resolutions passed at an Annual General Meeting—directly corresponds to the definition of AGM Information.
2023-05-31 Polish
Oświadczenie RN dla biegłego rewidenta dot. sprawozdania o wynagrodzeniach
Remuneration Information Classification · 98% confidence The document is a formal statement, signed by the Chairman of the Supervisory Board, addressed to the management regarding the assessment of the 'Sprawozdanie o wynagrodzeniach' (Remuneration Report) for the fiscal year ended December 31, 2022. It explicitly references Polish law concerning public offerings and remuneration disclosure (art. 90g, art. 90d of the 'Ustawa o ofercie publicznej'). The content is a detailed confirmation and assertion about the completeness and accuracy of the remuneration report, which is a key component of executive compensation disclosure. This aligns directly with the definition of Remuneration Information, which corresponds to the DEF 14A filing type in the US context, or its equivalent for disclosing executive compensation details.
2023-05-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.